News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,913 Results
Type
Article (86720)
Company Profile (703)
Press Release (763488)
Multimedia
Podcasts (138)
Webinars (18)
Section
Business (232767)
Career Advice (4130)
Deals (39744)
Drug Delivery (129)
Drug Development (91058)
Employer Resources (198)
FDA (18155)
Job Trends (17353)
News (396690)
Policy (39792)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (102)
Alliances (56931)
ALS (112)
Alzheimer's disease (1535)
Antibody-drug conjugate (ADC) (184)
Approvals (18103)
Artificial intelligence (366)
Autoimmune disease (34)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (374)
Cancer (2894)
Cardiovascular disease (232)
Career advice (3537)
Career pathing (34)
CAR-T (200)
CDC (34)
Cell therapy (550)
Cervical cancer (23)
Clinical research (73998)
Collaboration (1035)
Company closure (3)
Compensation (649)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (315)
Cystic fibrosis (117)
Data (2859)
Decentralized trials (2)
Denatured (48)
Depression (65)
Diabetes (330)
Diagnostics (6958)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (165)
Drug pricing (147)
Drug shortages (35)
Duchenne muscular dystrophy (122)
Earnings (97408)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131230)
Executive appointments (878)
FDA (19749)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (935)
Gene editing (141)
Generative AI (36)
Gene therapy (415)
GLP-1 (896)
Government (5224)
Grass and pollen (6)
Guidances (179)
Healthcare (20911)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (171)
Immuno-oncology (8)
Indications (36)
Infectious disease (3069)
Inflammatory bowel disease (162)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (114)
Interviews (813)
IPO (17883)
IRA (53)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (15)
Labor market (53)
Layoffs (582)
Leadership (25)
Legal (10126)
Liver cancer (83)
Lung cancer (412)
Lymphoma (200)
Machine learning (9)
Management (65)
Manufacturing (408)
MASH (92)
Medical device (14690)
Medtech (14695)
Mergers & acquisitions (22526)
Metabolic disorders (879)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (135)
Neuropsychiatric disorders (38)
Neuroscience (2242)
NextGen: Class of 2025 (7687)
Non-profit (5087)
Now hiring (46)
Obesity (465)
Opinion (285)
Ovarian cancer (96)
Pain (115)
Pancreatic cancer (111)
Parkinson's disease (189)
Partnered (25)
Patents (293)
Patient recruitment (142)
Peanut (53)
People (65577)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22852)
Phase II (32130)
Phase III (24191)
Pipeline (1599)
Policy (215)
Postmarket research (3552)
Preclinical (10316)
Press Release (72)
Prostate cancer (138)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (492)
Real estate (7397)
Recruiting (75)
Regulatory (26997)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (91)
Series A (159)
Series B (105)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (36)
Startups (4298)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (63)
The Weekly (88)
Vaccines (875)
Venture capitalists (51)
Weight loss (316)
Women's health (46)
Worklife (20)
Date
Today (154)
Last 7 days (569)
Last 30 days (2639)
Last 365 days (34858)
2025 (16452)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (66)
Alaska (7)
Arizona (278)
Arkansas (14)
Asia (50408)
Australia (8863)
California (7441)
Canada (2300)
China (676)
Colorado (319)
Connecticut (336)
Delaware (192)
Europe (115654)
Florida (1100)
Georgia (253)
Hawaii (1)
Idaho (65)
Illinois (708)
India (32)
Indiana (371)
Iowa (18)
Japan (218)
Kansas (115)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1067)
Massachusetts (5684)
Michigan (267)
Minnesota (463)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (72)
New Jersey (2077)
New Mexico (31)
New York (2088)
North Carolina (1210)
North Dakota (10)
Northern California (3211)
Ohio (243)
Oklahoma (16)
Oregon (48)
Pennsylvania (1591)
Puerto Rico (17)
Rhode Island (39)
South America (1653)
South Carolina (34)
South Dakota (1)
Southern California (2743)
Tennessee (121)
Texas (1117)
United States (28122)
Utah (221)
Virginia (199)
Washington D.C. (79)
Washington State (659)
West Virginia (4)
Wisconsin (82)
850,913 Results for "'".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Gilead Cuts 36 Employees in California
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
June 16, 2025
·
228 min read
·
BioSpace Editorial Staff
Collaboration
Partner-Seeking Biotechs Find Plenty of Hands To Shake as BIO2025 Kicks Off
At a satellite kickoff event to the annual BIO meeting, investment bankers and VCs gave reasons for optimism amid a ‘volatile’ period for the industry.
June 16, 2025
·
2 min read
·
Jef Akst
Weight loss
Lilly Notches ‘Top-Tier’ Weight Loss Results for Phase I Amylin/Tirzepatide Combo
At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were also impressed by the tolerability profile.
June 16, 2025
·
2 min read
·
Annalee Armstrong
Parkinson’s disease
Roche, Prothena Push Parkinson’s Drug to Phase III Despite Mid-Stage Fail
Analysts at Jefferies give Roche and Prothena’s Phase III study just a 25% to 40% probability of success.
June 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial
June 16, 2025
·
5 min read
Press Releases
Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy
First Patients Expected to be Enrolled This Month
June 16, 2025
·
1 min read
Press Releases
Integrated DNA Technologies Announces Innovation Roadmap Advances to Infectious Disease Portfolio
June 16, 2025
·
4 min read
Press Releases
Imbrium Therapeutics to Showcase Pipeline Assets Open for Partnership at the BIO International Convention 2025
June 16, 2025
·
3 min read
Press Releases
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
June 16, 2025
·
17 min read
Press Releases
PharmaDrug Announces Resignation of Rob Steen as CEO and From Board of Directors
June 16, 2025
·
1 min read
1 of 85,092
Next
